SAFE pathway and conditioning: from discovery to its effectiveness in the presence of cardiovascular risk factors
SAFE pathway and conditioning: from discovery to its effectiveness in the presence of cardiovascular risk factors
Imamdin, A. Hadebe, N. Lecour, S.
Imamdin, A.
Hadebe, N.
Lecour, S.
Abstract
Although ischemic conditioning has been described as the most powerful strategy to protect against ischemia-reperfusion injury, its translation to the clinical setting has proved to be challenging, possibly due, at least in part, to the presence of different cardiovascular risk factors in patients, which are known to affect its efficacy. Ischemic conditioning confers cardioprotection via the activation of multiple prosurvival pathways, including the activation of the survivor activating factor enhancement (SAFE) path, which involves mediators of the innate immune system (i.e. tumor necrosis factor alpha) and key transcription factors such as the signal transducer and activator of transcription 3 (STAT3). Here, we describe the origin of the SAFE path as a key pathway in ischemic conditioning and we explore how the activation of this path may be affected in the presence of different cardiovascular risk factors.
Description
Date
2020-05-05
Journal Title
Journal ISSN
Volume Title
Publisher
Open access
Collections
Research Projects
Organizational Units
Journal Issue
Keywords
Prosurvival signalling pathways , SAFE , Tumor Necrosis Factor , signal transducer and activator of transcription 3 , cardiovascular risk factors
Citation
Aqeela Imamdin1, Nkanyiso Hadebe1,2, Sandrine Lecour1SAFE pathway and conditioning: from discovery to its effectiveness in the presence of cardiovascular risk factors Conditioning Medicine